JFL Life Sciences (NSE:JFLLIFE) Beta: 0.8717 (As of Jun. 27, 2026)


NSE:JFLLIFE JFL Life Sciences Ltd NSE:JFLLIFE
65 GF Score
Price ₹9.05
GF Value ₹35.55
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is JFL Life Sciences Beta?

JFL Life Sciences NSE:JFLLIFE 65 Beta is 0.8717 as of Jun. 27, 2026. GuruFocus rates NSE:JFLLIFE with a GF Score™ of 65/100 and a GF Value™ of ₹35.55 (Significantly Undervalued). The stock has 2 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-27), JFL Life Sciences's Beta is 0.8717.

JFL Life Sciences  (NSE:JFLLIFE) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)

JFL Life Sciences Beta Related Terms

JFL Life Sciences Beta Historical Data

* Premium members only.

The historical data trend for JFL Life Sciences's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JFL Life Sciences Beta Chart

JFL Life Sciences Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Beta
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

JFL Life Sciences Semi-Annual Data
Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Beta Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

NSE:JFLLIFE vs ZTS: Beta Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, JFL Life Sciences's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

JFL Life Sciences Beta vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, JFL Life Sciences's Beta distribution charts can be found below:

* The bar in red indicates where JFL Life Sciences's Beta falls into.


NSE:JFLLIFE
65GF Score
JFL Life Sciences Ltd NSE:JFLLIFE
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

JFL Life Sciences Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 0.8717 mean?
JFL Life Sciences (NSE:JFLLIFE) has a Beta of 0.8717 as of Jun. 27, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for JFL Life Sciences and its competitors.
Is JFL Life Sciences' Beta too high?
JFL Life Sciences' current Beta is 0.8717. Overall, JFL Life Sciences has a GF Score™ of 65/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does JFL Life Sciences' Beta compare to ZTS?
JFL Life Sciences' Beta of 0.8717 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Drug Manufacturers company?
A good Beta depends on the Drug Manufacturers industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for JFL Life Sciences and its competitors. JFL Life Sciences's current Beta is 0.8717. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JFL Life Sciences stock overvalued right now?
Based on GuruFocus' analysis, JFL Life Sciences (NSE:JFLLIFE) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹35.55, compared to a current price of ₹9.05 — trading 74.5% below its estimated fair value. The current Beta is 0.8717. JFL Life Sciences' overall GF Score™ is 65/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For JFL Life Sciences (NSE:JFLLIFE), the current Beta is 0.8717 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is JFL Life Sciences (NSE:JFLLIFE) Overvalued in 2026?

Based on GuruFocus' analysis, JFL Life Sciences stock appears to be undervalued. The current stock price of ₹9.05 is trading 74.5% below its estimated GF Value™ of ₹35.55. GuruFocus considers JFL Life Sciences to be Significantly Undervalued.

Key valuation signals for NSE:JFLLIFE:

  • Beta: 0.8717
  • GF Value™: ₹35.55 vs. price of ₹9.05 (74.5% below fair value)
  • GF Score™: 65/100 with 2 warning signs

No single metric tells the full story. See the NSE:JFLLIFE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

JFL Life Sciences Business Description

Address Jodhpur Cross Road, 309, Satyam Mall, Opposite Saman Complex, Near Vishweshwar Mahadev Mandir, Settelite, Ahmedabad, GJ, IND, 380015
JFL Life Sciences Ltd is engaged in the business of manufacturing pharmaceutical products. The company's product portfolio consists of Dry powder injections (B-Lactam), Tablets and Capsules (B-Lactam) solid oral dosage forms, and general tablets and capsules. Its operating segment comprises of manufacturing and selling of pharmaceutical products. Geographically, the company sells its products both in India and outside India.
65GF Score

Get the complete analysis for NSE:JFLLIFE

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹9.05
Price
₹35.55
GF Value